Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Track & Trace – And Delay: Pharmacies Get Enforcement Discretion From FDA

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA's grace period for transaction information sharing means that distribution channels will operate more smoothly, but also could result in more missed deadlines down the road.


Related Content

Track And Trace Deadline Could Slip Again After Worries Over Inferencing
Drug Shortages Mostly FDA’s Fault, House Oversight Committee Concludes





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts